197 Followers on Owler
OverviewCompetitorsFundingNews & Insights

Eargo Funding History

Since Eargo was founded in 2010, it has participated in 9 rounds of funding. In total Eargo has raised $554.1M. Eargo's last funding round was on Nov 2022 for a total of $29.3M.

Eargo Funding Rounds

Unlock 6 more funding rounds →

ROUND

FUNDING DATE

AMOUNT

NUMBER OF INVESTORS

INVESTORS

Post-IPO Equity
Nov 2022
$29.3M
__
Post-IPO Debt
Jun 2022
$125M
1
Patient Square Capital.
IPO
Oct 2020
$141.3M
1
Series E
Jul 2020
$81.6M
6
Maveron,  New Enterprise Associates,  Gilde Healthcare,  Longitude Capital,  the Charles and Helen Schwab Foundation,  Nan Fung Life Sciences
Series D
Dec 2018
$52M
4
New Enterprise Associates,  The Charles and Helen Schwab Foundation,  Maveron,  Future Fund

Total Funding: $554.1M

Eargo Investors

Unlock 10 more investors →

INVESTOR

ROUND

FUNDING DATE

Patient Square Capital.
Post-IPO Debt
Jun 2022
Maveron
Series E, Series D, Series A
Jul 2020, Dec 2018, Jun 2015
New Enterprise Associates
Series E, Series D, Series C, Equity, Series B
Jul 2020, Dec 2018, Oct 2017, Jun 2017, Dec 2015
Gilde Healthcare
Series E
Jul 2020
Longitude Capital
Series E
Jul 2020

Total Investors: 13

Eargo has 13 investors, including Patient Square Capital., Maveron and New Enterprise Associates. The latest investment occurred in Nov 2022.